Wisconsin Overdose Deaths Drop 33% as Statewide Harm Reduction Strategy Takes Hold

Wisconsin recorded 1,185 drug overdose deaths in 2024, representing a 33% decline from the state's record high of 1,830 fatalities in 2022. The drop marks a significant reversal in a state that had seen overdose mortality climb steadily for years, with 2023 showing a modest decrease to 1,772 deaths before the sharper fall documented in the most recent state health data.

The improvement comes as Wisconsin communities have deployed millions of dollars from national opioid litigation settlements into harm reduction infrastructure, expanded medication-assisted treatment programs, and street-level outreach efforts. Public health officials and recovery advocates say the decline demonstrates that coordinated intervention can bend the mortality curve even as fentanyl continues to dominate the illicit drug supply.

From record highs to measurable progress

Wisconsin's overdose death trajectory followed a familiar pattern seen across the Midwest. The state saw fatalities climb through the late 2010s and early pandemic years, reaching the 2022 peak driven primarily by fentanyl and synthetic opioids. The subsequent 33% reduction over two years places Wisconsin among states achieving substantial declines in overdose mortality.

The Wisconsin Department of Health Services attributes the improvement to what officials describe as the "public health ecosystem working as intended"—multiple interventions reinforcing one another rather than any single program driving change. Naloxone distribution has expanded dramatically, with community organizations, health departments, and first responders distributing thousands of overdose reversal kits annually. Medication-assisted treatment for opioid use disorder has become more accessible through both traditional clinics and newer mobile units serving rural areas.

Milwaukee County leads with 42% reduction

Milwaukee County, which historically bore a disproportionate share of the state's overdose burden, has seen deaths fall from a peak of 674 in 2022 to 387 in 2024—a 42% decline that outpaces even the statewide improvement. The county has invested $111 million in opioid settlement funds into a comprehensive strategy spanning prevention, treatment, and recovery support.

The county's approach includes harm reduction vending machines that provide 24/7 access to naloxone, fentanyl test strips, and hygiene supplies; expanded community paramedic services that connect overdose survivors with treatment resources; and jail-based medication-assisted treatment programs that begin stabilization before release. County Executive David Crowley has emphasized that the decline, while encouraging, still leaves Milwaukee with an overdose mortality rate of 34.3 per 100,000—among the highest in Wisconsin and well above the state average.

Personal stories illustrate the human impact

Behind the statistics are individuals who have survived overdoses, entered treatment, and rebuilt their lives. Shawn Kress, a Milwaukee native who experienced homelessness and addiction for decades, represents the personal dimension of the public health data. After losing his brother to overdose and reaching what he describes as the lowest point of his life, Kress entered detox and residential treatment at Serenity Inns in 2024.

Now 14 months sober and working as a certified peer support specialist, Kress spends his days introducing newcomers to recovery programs. "I go and I introduce the program to newcomers that are very new, coming in off the streets and showing them that I'm one of the individuals that successfully completed the program," he told Wisconsin Public Radio. Kress credits the expansion of street-level resources for the broader decline in deaths. "The reason that I think the overdoses are starting to decline is because of the boots on the ground. We have resources now that are actually getting into the streets."

Settlement funds fuel infrastructure expansion

Wisconsin is receiving approximately $794 million in total opioid settlement funds through 2038, with the first major distributions beginning in 2024. The state has directed 70% of funds to county and local governments, a structure designed to ensure resources reach communities most affected by the epidemic.

Milwaukee's $17.1 million allocation approved in May 2026 exemplifies how jurisdictions are deploying settlement dollars. The four-stage framework dedicates $9.35 million to prevention, $4.83 million to treatment expansion, $3.58 million to community wellness initiatives, and $281,250 to recovery services. The Meta House residential treatment facility for women and children, which expanded from 35 to 100 beds with settlement support, represents the tangible infrastructure emerging from the funding.

Challenges remain as threats evolve

Despite the encouraging trends, Wisconsin public health officials caution that the crisis is far from resolved. Fentanyl remains the primary driver of overdose deaths, involved in the majority of fatalities. The state has also seen emerging threats from xylazine and medetomidine—veterinary tranquilizers that complicate overdose response and create severe withdrawal syndromes.

Rural areas continue to face significant barriers to treatment access, with residents in some northern and western Wisconsin counties driving 90 minutes or more to reach medication-assisted treatment providers. The state's methadone regulations remain more restrictive than federal standards, creating what advocates call "golden handcuffs" that limit patient flexibility.

Federal policy uncertainty adds another layer of concern. The Trump administration's elimination of SAMHSA funding for fentanyl test strips and proposed cuts to harm reduction programs threaten tools that Wisconsin communities have credited with reducing mortality. State officials say they are working to backfill federal reductions with settlement funds, but the long-term sustainability of harm reduction infrastructure remains uncertain.

Looking ahead

Wisconsin's 33% decline in overdose deaths demonstrates that the mortality curve can bend when communities invest in evidence-based interventions at sufficient scale. The state's experience aligns with national data showing a 14% decline in overdose deaths nationwide, suggesting that expanded naloxone access, medication-assisted treatment, and harm reduction approaches are having measurable impact across diverse jurisdictions.

For individuals like Shawn Kress, the statistics represent something more personal: the possibility that others might avoid the losses he experienced. "I didn't want to go back to the tent, I didn't want to go back to the streets, I didn't want to use anymore," Kress said of his decision to seek treatment. With expanded resources now reaching people in similar circumstances, Wisconsin's decline in overdose deaths suggests that more individuals are finding pathways to recovery.